Condition (MeSH)
Nail-Patella Syndrome
ClinicalTrials.gov lists 2 trials for Nail-Patella Syndrome or a narrower condition beneath it. National Human Genome Research Institute (NHGRI) has the most among industry and government lead sponsors, with 1.
Search trials, drugs, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Rows recorded per section
2 sections measured, none recorded · 1 not measured yet · 1 not computed
2 of the 2 trials are tagged with Nail-Patella Syndrome itself; the rest are tagged with a narrower condition beneath it.
When did Nail-Patella Syndrome trials start? (2)
Shown in this order: most recent first, 1990 onwards. 2026 is partial: trials registered with a 2026 start date so far, not a full year.
| Year | Trials started |
|---|---|
| 2009 | 1 |
| 1997 | 1 |
No forecast is made for this condition: it averages 0.0 trial starts a year over the five years to September, under the 5 a year the method needs.
Recruitment duration, a model prediction: none of the 2 trials evaluated at the 2026-10-09 snapshot is predicted and still running. Source: ClinicalTrials.gov / AACT (CTTI), public domain.
What phase are Nail-Patella Syndrome trials in? (1)
Shown in this order: phase order.
| Phase | Trials |
|---|---|
| Observational | 2 |
How many Nail-Patella Syndrome trials are recruiting? (2)
Shown in this order: the order a trial moves through, from not yet recruiting to unknown.
| Status | Trials |
|---|---|
| Recruiting | 1 |
| Completed | 1 |
Status as registered on ClinicalTrials.gov. Each trial is counted once.
Which lead sponsors run the most Nail-Patella Syndrome trials? (1)
Shown in this order: most trials first. Lead sponsors the registry classes as industry, NIH, US federal, other government or network. A hospital or university the registry files as government can appear here. Sponsors it classes as academic or other are shown on the full page, because that class cannot separate an institution from a named investigator.
| Sponsor | Trials |
|---|---|
| National Human Genome Research Institute (NHGRI) | 1 |
Which publications cover Nail-Patella Syndrome? (1)
Shown in this order: major-topic papers first, then newest, then most linked to trials.
| Publication | Journal | Year | Major topic |
|---|---|---|---|
| [LMXb1 generates the morphology of podocytes]. | Archives de pediatrie : organe officiel de la Societe francaise de pediatrie | 2002 | No |
Prevalence (12)
Shown in this order: jurisdiction, then disease name. Orphanet observation for the mapped ORPHA concept; the mapping relation column says whether that concept is exactly this condition or broader or narrower.
| Orphanet disease | Type | Class | Geography | Jurisdiction | Mapping relation |
|---|---|---|---|---|---|
| Nail-patella syndrome | Point prevalence | 1-9 / 100 000 | United Kingdom | GB | Exact |
| Nail-patella syndrome | Point prevalence | 1-9 / 100 000 | United Kingdom | GB | Unspecified |
| Nail-patella syndrome | Point prevalence | 1-9 / 100 000 | United Kingdom | GB | Exact |
| Nail-patella syndrome | Prevalence at birth | 1-9 / 1 000 000 | Europe | Not stated | Exact |
| Nail-patella syndrome | Point prevalence | 1-9 / 100 000 | Worldwide | Not stated | Exact |
Showing 5 of 12 prevalence observations.
Rare-disease identity (2)
Shown in this order: exact, broader, narrower, other.
| Orphanet disease | ORPHA code | Relation | Source |
|---|---|---|---|
| Nail-patella syndrome | 2614 | Exact | Orphadata Science knowledge files, Product 1 |
| Nail-patella syndrome | 2614 | Exact | Orphanet Rare Disease Ontology (ORDO) |
Not on this page
Not measured: delivery record.
Checked, with nothing recorded for this condition: serious adverse events in this condition's trials and sub-conditions in mesh.
Not computed for conditions with fewer than 10 trials: drugs tested.